BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

MDA Virtual Learning Series: Amyotrophic Lateral Sclerosis (ALS)

Every Thursday evening from May 4th - June 1st
Event Time: 6:00-7:00pm EST
Live, Virtual Event

There is no cost to members of the MDA community or healthcare providers to attend the event, however registration is required. Members of the biopharma industry interested in sponsoring or attending should contact the MDA Healthcare Partnerships team at MDAPartners@mdausa.org. For all other questions, please reach out to mdaengage@mdausa.org.

View On-Demand

Please join us for our upcoming MDA Virtual Learning Series: Amyotrophic Lateral Sclerosis (ALS). This new disease-specific virtual learning event will take place over 5 weeks, starting on Thursday, May 4th. Every Thursday, join us at 6:00pm EST for updates and information related to ALS. This virtual series will provide individuals and families with important knowledge and resources specific to ALS.

Topics being discussed include updates in ALS research, physical therapy and adaptive equipment, financial planning, respiratory care, and a caregiver panel discussion for ALS caregivers.

Live questions will be taken during the webinar. Not available to join live?; Register to receive an email when the webinar is available for on-demand viewing.

If you have questions about this webinar or other MDA Engage programs, please reach out to mdaengage@mdausa.org or you may contact our MDA Resource Center at 1-833-ASK-MDA1 (275-6321) or ResourceCenter@mdausa.org.

MDA Thanks our sponsors:

  • Cytokinetics
  • Mitsubishi Tanabe Pharma, America